Petra Loos, Frankfurt Am Main DE
Petra Loos, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20110301081 | LONG-ACTING FORMULATIONS OF INSULINS - The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine. | 12-08-2011 |
20120122774 | LONG-ACTING FORMULATIONS OF INSULINS - The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine. | 05-17-2012 |
20140206611 | LONG-ACTING INSULIN FORMULATIONS - The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine. | 07-24-2014 |
20140221285 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES - Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed. | 08-07-2014 |
20150119323 | Stable Formulation of Insulin Glulisine - An aqueous pharmaceutical formulation comprising 200-1000 U/mL of insulin glulisine. | 04-30-2015 |
20150190475 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART - Stabilized pharmaceutical formulations of insulin aspart are disclosed. | 07-09-2015 |
20150216941 | Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives - Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed. | 08-06-2015 |
20150216981 | Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives - Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed. | 08-06-2015 |